Effect of tamoxifen on 1,2-Dimethylhydrazine-HCl-induced colon carcinogenesis in rats

Anticancer Research

Volumn 17, Issue 2 A, 1997, Pages 803-810

  Ziv, Yehiel ^a,d   Fazio, Victor W ^a   Kitago, Kuniaki ^a   Gupta, Manjula K ^a   Sawady, Joram ^b   Nishioka, Kenji ^c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b METROHEALTH MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d ASSAF HAROFEH MEDICAL CENTER   (Israel)

Author keywords

Chemoprevention; Colon cancer; Dimethylhydrazine; Estrogen receptors; Ornithine decarboxylase; Polyamines; Rats; Tamoxifen

Indexed keywords

1,2 DIMETHYLHYDRAZINE; ESTRADIOL; ESTROGEN RECEPTOR; ORNITHINE DECARBOXYLASE; POLYAMINE; TAMOXIFEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCULATION; CANCER INCIDENCE; COLON CANCER; COLON CARCINOGENESIS; COLON MUCOSA; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ESTRADIOL BLOOD LEVEL; FEMALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

1,2-DIMETHYLHYDRAZINE; ANIMALS; BIOGENIC POLYAMINES; CARCINOGENS; COLONIC NEOPLASMS; DIMETHYLHYDRAZINES; ESTROGEN ANTAGONISTS; FEMALE; ORNITHINE DECARBOXYLASE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ESTROGEN; SEX FACTORS; TAMOXIFEN;

EID: 0030890088     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Boring CC, Squires TS, Tong T: Cancer statistics 43: 7-26, 1993.
2. Wolmark N, Fisher B, Rockette H, Redmond C, Wickerham DL, Fisher ER, et al: Postoperative adjuvant chemotherapy or BCG for colon cancer. J Natl Cancer Ins 80: 30-36, 1988.
3. Lynch HT, Lynch PM, Keathley J: Epidemiology of colon cancer. In: Lynch PM, Lynch HT, editors. Colon cancer genetics, New York Von Nortrand Reinhold Company 25-48, 1985.
4. Tutton PJM, Barkla DHB: Steroid hormones as regulators of the proliferative activity of normal and neoplastic intestinal epithelial cells. Anticancer Res 8: 451-456, 1988.
5. Morris DL, Watson SA, Durrant LG, Harrison JD: Hormonal control of gastric and colorectal cancer in man. Gut 30: 425-429, 1989.
6. Odagiri E, Jibiki K, Kato Y, Nakamura S, Oda S, Demura R, et al: Steroid receptors in dimethylhydrazine-induced colon carcinogenesis. Cancer 56: 2627-2634, 1985.
7. Baum M, Ziv Y, Colletta A: Prospects for the chemoprevention of breast cancer. Brit Med Bull 47: 493-503, 1991.
8. Porter CW, Herrera-Ornelas L, Pera P, Petrelli NF, Mittelman A: Polyamine biosynthetic activity in normal and neoplastic human colorectal tissues. Cancer 60: 1275-1281, 1987.
9. DiLeo A, Linsalata M, Cavallini A, Messa C, Rosso F: Sex steroids hormone receptors, epidermal growth factor and polyamines in human colorectal cancer. Dis Colon Rectum 35: 305-309, 1992.
10. Jordan VC: Effect of tamoxifen on initiation and growth of DMBA-induced rat mammary carcinoma. Eur J Cancer Clin Oncol 12: 419-424, 1976.
11. Cuzick J, Baum M: Tamoxifen and contralateral breast cancer. Lancet i: 282, 1976.
12. Jordan VC, Lababidi MK, Langan-Fahey S: Suppression of mouse mammary tumorigenesis by long-term tamoxifen therapy. J Natl Cancer Inst 83: 492-496, 1991.
13. Leu SY, Hsu H: In vivo tamoxifen modulation of colorectal cancer by the subrenal capsule assay [abstract]. Dis Colon Rectum 35: 16, 1993.
14. Greene FL, Lamb LS, Barwick M: Colorectal cancer in animal modelc - A review. J Surg Res 43: 476-487, 1987.
15. Madara JL, Harte P, Deasy J, ROSS D, Lahey S, Steele G: Evidence of an adenoma-carcinoma sequence in DMH-induced neoplasms of rat intestinal epithelium. Am J Pathol 110: 230-235, 1983.
16. Wilson RB, Hutcheson DP, Wideman L: Dimethylhydrazine-induced colon tumors in rats fed diets containing beef fat or corn oil with and without wheat bran. Am J Clin Nutr 30: 176-181, 1977.
17. Pratt IJ: Steroids in clinical chemistry. Clin Chem 24: 1869-1890, 1978.
18. Lowry OH, Rosenbraugh NJ, Farr AL, Randall RJ: Protein measurements with the folin phenol reagent. J Biol Chem 193: 265-275, 1951.
19. McGuire WL, LaGarza MD, Chammern C: Evaluation of estrogen receptor assays in human breast cancer tissue. Cancer Res 37: 637-639, 1977.
20. Scatchard G: The attraction of proteins for small molecules and ions. Ann NY Acad Sci 51: 660-672, 1949.
21. Harris WB, Grossie VB, Ota DM, Nishioka K, Ajani JA, Chang T, et al: Effect of difluoromethylornithine on host and tumor polyamin metabolism during total parenteral nutrition. J Surg Res 38: 592-598, 1985.
22. Shin DM, Gimenez IB, Slaga TJ, Lee JS, Nishioka K, Wargovitch MJ et al: Expression of epidermal growth factor receptor, polyamine levels, osrnithine decarboxylase activity, micronuclei, and transglutaminase I in a DMBA-induced hamster buccal pouch carcinogenesis model. Cancer Res 59: 2505-2510, 1990.
23. Sporn MB: Carcinogenesis and cancer: different perspectives on the same disease. Cancer Res 51: 6215-6218, 1991.
24. O'Brien CA, Liskamp RM, Solomon DH, Weinstein B: Inhibition of protein kinase C by tamoxifen. Cancer Res 45: 2462-2465, 1985.
25. Meggouh F, Lointier P, Pezet D, Saez S: Status of sex steroid hormone receptors in large bowel cancer. Cancer 67: 1964-1970, 1991.
26. Rothbauer E, Mann K, Wiebecke B: Epidermal growth factor receptors and epidermal growth factor-like activity in colorectal mucosa, adenoma and adenocarcinoma. Klin Wochenschr 67: 518-523, 1989.
27. Loser C, Folsch UR, Paprotny C, Creutzfeldt W: Polyamines in colorectal cancer. Cancer 65: 958-966, 1990.
28. Kingsnorth AN, Lumsden AB, Wallace HM: Polyamines in colorectal cancer. Br J Surg 71: 791-794, 1984.
29. Bolander FF: Molecular endocrinology. San Diego: Academic Press 205-227, 1989.